Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Mar;14(3):182-6.
doi: 10.1111/j.1468-1293.2012.01035.x. Epub 2012 Jul 17.

Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults

I I Bogoch  1 , J R Andrews, E H Nagami, A M Rivera, R T Gandhi, D Stone
Affiliations
Multicenter Study

Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults

I I Bogoch et al. HIV Med. 2013 Mar.

Abstract

Objectives: The aim of the study was to determine the aetiology and clinical predictors of peripheral lymphadenopathy in HIV-infected individuals during the antiretroviral (ARV) era in a nontuberculosis endemic setting.

Methods: A multicentred, retrospective cohort study of peripheral lymph node biopsies in HIV-positive adults was carried out. A total of 107 charts were identified and reviewed for clinical features, lymphadenopathy size, and ARV use and duration. Biopsy results were categorized, and multivariate logistic regression determined independent predictors of lymphadenopathy aetiology.

Results: Evaluation of 107 peripheral lymph node biopsies revealed that 42.9% of peripheral lymphadenopathy was attributable to malignancy, 49.5% to reactive changes, and 7.5% to infections, with only 2.8% of all cases secondary to tuberculosis. Fevers, weight loss, ARV use, and lower viral loads are significantly associated with nonreactive lymphadenopathy.

Conclusions: Lymphadenopathy is likely to be reactive or malignant in nontuberculosis endemic regions. Readily available clinical features can aid clinicians in predicting the underlying aetiology, those at risk for malignancy, and who to biopsy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

IIB – none; JRA – none; EHN - none; AMR - none; RTG - none; DS - none

References

    1. Bottles K, McPhaul LW, Volberding P. Fine-needle aspiration biopsy of patients with acquired immunodeficiency syndrome (AIDS): experience in an outpatient clinic. Ann Intern Med. 1988;108(1):42–45. - PubMed
    1. Reid AJ, Miller RF, Kocjan GI. Diagnostic utility of fine needle aspiration (FNA) cytology in HIV-infected patients with lymphadenopathy. Cytopathology. 1998;9(4):230–239. - PubMed
    1. Wong R, Rappaport W, Gorman S, et al. Value of lymph node biopsy in the treatment of patients with the human immunodeficiency virus. Am J Surg. 1991;162(6):590–592. - PubMed
    1. Kamana NK, Wanchu A, Sachdeva RK, et al. Tuberculosis is the leading cause of lymphadenopathy in HIV-infected persons in India: results of a fine-needle aspiration analysis. Scand J Infect Dis. 2010;42:827–830. - PubMed
    1. Vanisri HR, Nandini NM, Sunila R. Fine-needle aspiration cytology findings in human immunodeficiency virus lymphadenopathy. Indian J Pathol Microbiol. 2008;51(4):481–484. - PubMed

Publication types

MeSH terms